The diagnostic value of serum YKL-40 for myocardial involvement in idiopathic inflammatory myopathy
- 1 November 2022
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 537, 167-172
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- T1, T2 Mapping and Extracellular Volume Fraction (ECV): Application, Value and Further Perspectives in Myocardial Inflammation and CardiomyopathiesRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 2015
- Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low-grade skeletal muscle disease activityAnnals of the Rheumatic Diseases, 2015
- Cardiac Involvement in Adult Polymyositis or Dermatomyositis: A Systematic ReviewClinical Cardiology, 2012
- Can YKL-40 be a new inflammatory biomarker in cardiovascular disease?Immunobiology, 2012
- Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and InjuryAnnual Review of Physiology, 2011
- YKL-40: A New Biomarker in Cardiovascular Disease?Biomarkers in Medicine, 2010
- Autoimmune myocarditis: Past, present and futureJournal of Autoimmunity, 2009
- Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13–induced tissue responses and apoptosisJournal of Experimental Medicine, 2009
- Standardizing the Definition of Hyperenhancement in the Quantitative Assessment of Infarct Size and Myocardial Viability Using Delayed Contrast-Enhanced CMRJournal of Cardiovascular Magnetic Resonance, 2005
- Serum skeletal troponin I in inflammatory muscle disease: relation to creatine kinase, CKMB and cardiac troponin IAnnals of the Rheumatic Diseases, 2000